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Mammalian organs comprise a variety of cells that
interact with each other and have distinct biological
roles. Access to evaluate and perturb intact biological
systems at the cellular and molecular levels is essential to
fully understand their functioning in normal and
diseased conditions, yet technical limitations have
constrained most research to small pieces of tissue.
Tissue clearing and optogenetics can help overcome this
hurdle: tissue clearing affords optical interrogation of
whole organs at the molecular level, and optogenetics
enables the scalable control and measurement of cellular
activity with light. In this Q&A, we delineate recent
advances and practical challenges associated with these
two techniques when applied body-wide.with high temporal precision. Recently developed toolsHow can tissue clearing and optogenetics benefit
the study of diseases?
Mammalian organs are highly coordinated, complex net-
works of cells. Our understanding of organ physiology and
pathology would benefit from study of the structures and
even organisms as a whole; however, technical limitations
have historically forced most preclinical research to focus
on small pieces of organ tissue, rather than intact organs. In
neuroscience, efforts have been made to understand the
brain as a whole system while maintaining cell and/or
circuit resolution, resulting in substantial advances in
technologies such as tissue clearing (TC), optogenetics, and
gene delivery via viral vectors. Recent developments in TC
have greatly increased our ability to interrogate whole
organs—and even whole organisms—by rendering the* Correspondence: viviana@caltech.edu
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niques, this has the advantage of leaving complex intercellu-
lar pathways intact and retaining dispersed, subtle features
[1–3]. This allows us not only to study the 3-D structure of
normal tissue in unprecedented detail, but also to investi-
gate sparsely distributed pathological hallmarks in disease
models; for example, amyloid plaques in the brain of Alzhei-
mer’s disease mouse models [4]. While TC has been instru-
mental in mapping the streets, so to speak, optogenetic
tools are used to monitor and control the traffic, or activity,
that uses these pathways. These methods are therefore used
synergistically: TC is conducted post-mortem whereas opto-
genetics is a real-time technique that, defined broadly, uses
light to either manipulate or report [5] neuronal activity
in vivo. In combination with genetic targeting strategies,
optogenetics allows researchers to study cellular populations
allow us to control and record from highly specific popula-
tions of neurons in broadly distributed neural networks [6].
This approach has revealed various functional circuits
spanning across brain regions [7, 8], providing potential
therapeutic targets for neurological disorders. Beyond
neuroscience, TC and optogenetic techniques have enabled
a new research pipeline for the study of diseases, allowing
us to access and assess the anatomy and functions of a
broad range of biological systems, including the peripheral
nervous system, more precisely than before.There are so many tissue clearing methods, which
one to use?
By and large, there is no ‘one size fits all’ method for TC—it
is application dependent. Each clearing method has its own
strengths and weaknesses, and many tradeoffs need to be
considered, such as: compatibility with immunohistochem-
istry (IHC) and fluorescence in situ hybridization (FISH),
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tissue), and clearing time. For a comprehensive comparison
of TC methods refer to [1, 2, 9]. Given the variability in
clearing results, we recommend trying a few TC methods
in parallel and selecting the one that satisfies the experi-
mental endpoints.
In our work, we typically utilize the passive clarity tech-
nique (PACT), which retains endogenous fluorescence
[10, 11], is compatible with IHC and single molecule FISH
(smFISH), and provides excellent clearing results. How-
ever, PACT can be a time-consuming method and the
cleared tissue expands [10], a property that was also re-
cruited by expansion microscopy [12], since this expan-
sion can be controlled or amplified (ePACT) in beneficial
ways as it also preserves endogenous fluorescence [11,
13]. PACT begins with paraformaldehyde (PFA) perfusion
and post-fixation stages, followed by hydrogel embedding.
When the hydrogel is polymerized, it acts as a scaffold
and locks proteins, DNA, and RNA in place for subse-
quent detection (Fig. 1a). Because the light-scattering
lipids are not anchored to the hydrogel, they can be re-
moved by a relatively gentle detergent, sodium dodecyl
sulfate (SDS), that leaves most epitopes and fluorescent
proteins well preserved. The hydrogel composition is vital;
it needs to be sufficiently dense to lock the proteins firmly,
yet sparse enough to allow detergent to flow throughout
the sample to wash away the opaque lipids. When using a
continuous conductive flow (Fig. 1b), an entire adult
mouse brain can be cleared and imaged using PACT
(Fig. 1c).
Can tissue clearing be applied to any organ?
Although TC techniques have been demonstrated mostly
in the brain, all soft organs can be successfully cleared
with various TC techniques, either by transcardial perfu-
sion, in which the clearing reagents are delivered
through the vasculature to the entire body [10, 11, 14],
or by dissecting, extracting, and clearing a specific organ
of interest. The extension of TC from the brain to the
rest of the body has resulted in a myriad of applications,
for example: profiling cancer metastasis in a whole or-
ganism [15] and studying axon regeneration in the per-
ipheral nervous system (PNS) after spinal cord injury
[16]. The PNS is essential for peripheral organ functions
such as the control of hormone secretion in the pan-
creas and autonomous beating of the heart. Because per-
ipheral nerve fibers densely innervate peripheral organs,
TC techniques will greatly enhance the study of interac-
tions between the PNS and organ functions, as well as
related diseases.
Besides soft tissue, organs with unique structures and/or
composition (such as bones) have recently been cleared
with a modified TC technique (Bone CLARITY [17];
Fig. 1d; details discussed below). Amongst other benefits,this method can now enable clearing of the intact skull,
allowing researchers to study not only the structure of the
brain per se, but also the delicate interface between bone
and brain, where the lymphatic vessels reside [18, 19].
Can we apply tissue clearing techniques to study
human organs?
Yes, this is possible, although factors regarding fixation,
labeling, scalability, and adaptability must be consid-
ered. Typically, the first step in TC methods is to re-
move blood and fix the organs of the animal model via
transcardial perfusion. During this process, formalde-
hyde is perfused through the vasculature of the post-
mortem animal to prevent the tissue from decompos-
ing. This makes it possible to achieve a uniform fixation
and to reach difficult-to-access locations throughout
the animal’s body. Since perfusion is not widely used in
post-mortem humans and is challenging in excised tis-
sue (from biopsies, for instance; the Langendorff is a
niche option for explanted hearts from transplantation
surgery [20]), immersion-based fixation is typically
used. The immersion-based fixation method results in
suboptimal preservation of proteins and epitopes, po-
tentially causing the loss of biological signals, and diffi-
culties in labeling of other significant biomolecules,
especially RNA. These labeling issues are aggravated in
tissues rich in enzymes/proteases such as the pancreas
or gut. Also, existing human tissue is usually collected
and stored flash frozen or as formalin-fixed, paraffin-
embedded sections, which is not fully compatible with
current TC and biomolecule labeling methods. Al-
though a few successful attempts at human tissue clear-
ing have been reported [11, 21], the formalin-based
fixation of human tissue causes the TC and antibody la-
beling steps to be more time consuming.
Additional considerations concerning the distinct
biological composition of human tissue compared
with rodent tissue require further optimization of TC
and staining procedures. For example, human brain
samples require longer clearing time to become trans-
parent than mouse brain samples with the same
thickness [22]. Even though human tissue specimens
acquired in clinical circumstances are often heteroge-
neous and fragile, embedding them in firming hydro-
gel and clearing is possible, even for challenging
samples such as the pancreas [23]. However, some
challenges to be aware of when working with human
samples are: (1) residual blood autofluorescence,
which makes imaging difficult; (2) suboptimal fixation
(under or over crosslinking that can lead to protein
degradation or epitope masking respectively); (3)
many antibodies used for rodent studies are not
suitable for human tissue, as the epitopes of proteins
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Fig. 1. Hydrogel-based clearing methods and their application to whole-brain and intact-bone clearing. a The protein retention mechanism and the
lipid removal process. Prior to lipid removal, the proteins are anchored to a hydrogel scaffold via PFA-mediated binding. During the clearing process,
the detergent selectively removes light scattering lipids, while proteins remain locked in place by the hydrogel. Following lipid removal, the tissue is
rendered transparent. b The clearing chamber and its components. With the use of continuous conductive flow, the clearing process is accelerated
(~ 2–3× faster) and can clear a whole brain or an entire bone. From [17]. Reprinted with permission from AAAS. c Maximum intensity projection of a
PACT-cleared whole mouse brain (Thy1-YFP) and a digital section (1 mm deep). d Maximum intensity projection of a mouse femur cleared using Bone
CLARITY, and a digital section (0.4 mm deep). The green channel represents auto-fluorescence, while the red channel represents cells that express Sox9.
The images in c and d were captured using a commercial and custom light-sheet microscope, respectively. From [17]. Reprinted with permission
from AAAS
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the procedure, such as sample processing time, image
acquisition time, data size, and processing time, scale
linearly. Consequently, because human organs are
much larger than rodent organs, there is a great need
to develop high-throughput microscopes with very
long working distances and more efficient ways to
handle big data.
What kinds of biomolecules can be labeled in
cleared tissue?
Most TC techniques are compatible with protein IHC
[11, 24]. Nonetheless, immunohistochemical labelingof proteins via antibodies is a lengthy process that
generally takes a few days as the antibodies diffuse
slowly through the thick tissue. In PACT, to help
antibody penetration and to ensure high-quality and
uniform staining across large cleared organs, the
organ is often bisected or sliced into thick sections
(~2 mm). Systemic delivery of antibodies and the use
of small molecules such as nanobodies are additional
options to circumvent antibody penetration issues
without sectioning the tissue. Recently it was reported
that the use of a small amount of detergent during
the antibody incubation time could improve penetra-
tion and labeling uniformity [25].
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cleared tissue, first demonstrated in Yang et al. [10]. The
ability to label RNAs is crucial to providing a ‘snap-shot’ of
cell state at a precise time point. Recent studies have shown
that RNA retention can be improved in hydrogel-based
clearing methods by adding chemical linkers or an add-
itional post-fixation step [26, 27]. However, because it pro-
duces a weak signal relative to the background, FISH is
only applicable to shallow depths within thick cleared tissue
samples [10]. Hybridization chain reaction (HCR) is used to
overcome this barrier and can boost the fluorescence signal
by an order of magnitude [26–29]. HCR is a non-linear
amplification method that uses DNA probes designed to
bind the target RNA and trigger self-assembly of
fluorophore-conjugated DNA hairpins (Fig. 2a). When
HCR is combined with TC, it is possible to detect single
mRNA transcripts in 0.5 mm-thick mouse brain tissue
(Fig. 2b) [26] and rRNA in sputum samples [30]. As the la-
beled RNA photo-bleaches relatively fast, imaging thick
cleared tissue benefits from using light sheet microscopy
and/or anti-fade buffer [26]. Recently, sequential
hybridization and barcoding techniques have enabled the
transcriptional profiling of more than 100 genes from thou-
sands of single cells, while maintaining their native environ-
ment in the tissue or cell culture [31, 32]. Although these
results were not obtained in a cleared tissue, they provide
the technical framework to achieve highly multiplexed
RNA profiling of individual cells in thick cleared tissue. Fur-
thermore, the smaller size of the probes facilitates diffusion
into deep tissue, thus accelerating the tissue-staining stage
in comparison to IHC (Fig. 2c). In addition, applying both
FISH and IHC to the same tissue is also feasible when la-
beling limitations arise, such as limited antibody availability
or RNA probe design difficulties due to sequence homology
[33] (Fig. 2c).
What are the preferred imaging devices for tissue
clearing?
Standard confocal microscopy is the most convenient op-
tion for high-resolution and small-volume image acquisi-
tion of cleared tissue [34, 35]. However, it is impractical to
image entire organs with a confocal microscope as the
microscope scans the sample point by point, resulting in
extremely long acquisition times and sample photobleach-
ing. To overcome these obstacles, we recommend using
light sheet microscopy (LSM). LSM is ~ 10–100 times fas-
ter than a typical confocal microscope because it images
an entire plane at a time [36]. Also, since LSM illuminates
only one plane at a time (the plane that is being acquired),
photobleaching is minimized [36, 37]. Imaging using LSM
is a big time-saver—entire organs can be imaged in only a
few hours. Nevertheless, the expected resolution in trad-
itional LSM is inferior to confocal microscopy [38].
Recently, customized light-sheet set-ups with improvedperformance have been introduced for TC. These micro-
scopes utilize long working distance objective lenses
(~8 mm), adaptively compensate for refractive index varia-
tions to reduce aberrations, and synchronize the illumin-
ation beam with the camera readout to improve the
signal-to-noise ratio [17, 34].
Can we detect changes in neuronal activity in
cleared tissue?
It is possible to detect changes in neuronal activity via
the use of TC methods. TC captures a snapshot of the
tissue at a moment in time, which affords the inference
of neuronal activity at that time. An increase in neuronal
activity can be identified either by staining for immediate
early genes (IEGs), such as c-fos [24], or by utilizing a
genetic system where active neurons are permanently la-
beled [39]. In the latter, a behavioral experiment is con-
ducted during a ~ 12-h period of tamoxifen induction
that enables Arc, an IEG, to drive fluorescent protein
expression [39]. This requires the use of a tamoxifen-
dependent Cre recombinase (CreER) [40] that can
remove floxed-stop sites to drive fluorescence reporter
expression when tamoxifen is delivered systemically.
These methods offer insight into brain-wide information
processing. An additional option that might provide a
faster readout is RNA FISH. Given that mRNA tran-
scription occurs prior to protein translation, RNA FISH
could detect upregulation of IEG mRNA immediately
after a behavioral experiment. However, TC techniques
cannot measure real-time neuronal activity.
What tools are available to monitor cell state and
physiological activity in live tissue?
Real-time monitoring of cellular physiology is an essential
component of systems and behavioral neuroscience studies.
Classic techniques use implanted electrodes to monitor
electrical activity and can determine neuronal firing with
high temporal precision. However, because electrophysio-
logical signatures are similar among cell types yet can also
widely vary within specific populations, it is difficult to de-
termine the precise neuronal type from which one is re-
cording. The development of genetically encoded calcium
indicators and voltage indicators (GECIs and GEVIs,
respectively) has been instrumental in overcoming this obs-
tacle by relying on changes in fluorescent protein intensities
to monitor activity-dependent calcium dynamics or
changes in membrane voltage [41, 42]. Once GECIs or
GEVIs are expressed in a desired neuronal population, fiber
photometry or two-photon imaging is used to detect the
activity of large neuronal ensembles in vivo. Although the
use of microelectrode arrays has increased the number of
units that can be recorded simultaneously [43], standard
electrophysiological techniques still have a lower through-
put than these genetic methods. While the temporal
ac
b
Fig. 2. RNA detection at depth by hybridization chain reaction. a The probe hybridization step and the HCR amplification step. In the
hybridization step, ~ 10–20 DNA probes bind to the target RNA. These probes carry the initiators for the HCR amplification step. In the
HCR amplification step, each initiator triggers the binding of two hairpin types in order to amplify the fluorescence signal. b Detection of
SCG10 mRNA transcripts in thick and cleared mouse brain 136 μm from the tissue surface. Adapted from [26]. c Simultaneous labeling of
mRNA transcripts and proteins using HCR and antibody staining (IHC) in uncleared tissue expressing endogenous fluorescent proteins
(YFP). During the same period of time (18 h), HCR achieved uniform labeling of mRNA transcripts through the tissue section, whereas
protein IHC only reached a shallow depth (~ 10 μm) below the surface (YZ view). The tissue section was soaked in refractive index matching
solution for imaging up to 50 μm deep into the tissue. Magnified inserts: note a subset of cells show TH mRNA but not TH protein signal
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cordings, activity indicators are constantly being improved
for faster and optimized performance [44]. The develop-
ment of these optogenetic reporters of in vivo neuronal ac-
tivity has complemented a separate class of optogenetic
tools used to inhibit and excite neuronal populations.
How have optogenetic tools evolved to study
diseases?
Since a microbial light-gated ion channel was first adapted
for use in mammalian cells, countless efforts have been
made to modify the protein or discover novel channels to
address different experimental needs. This has resulted in
effectors with improved sensitivity, broadened spectralproperties, and altered ion conductance to control neur-
onal activity, and their use has become a staple in systems
neuroscience research. Channelrhodopsin (ChR2), a light-
activated cation channel, is used ubiquitously in neurosci-
ence research to control neuronal excitation with blue
light [45]. Halorhodopsin (NpHR), meanwhile, is a light-
gated chloride pump that is activated in response to
yellow-green light and can inhibit neurons [46]. Both
ChR2 and NpHR have been used in numerous studies to
dissect neurobiological circuits relevant to many disor-
ders, including Parkinson’s disease [47], mood disorders
[48], and drug addiction [49]. Many other optogenetic ef-
fectors have been characterized and groups are tirelessly
working to modify and engineer novel molecules to
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ants with ultrafast control and increased currents [51].
Describing the advantages of each variant is beyond the
scope of this Q&A; however, several comprehensive re-
sources are easily accessible [52, 53].
Delivery of both actuators and sensors to the brain is not
without challenge as the widely used method of direct
intracranial injection only provides limited and non-
uniform expression. The recent development of novel viral
capsids that can effectively traverse the blood–brain barrier
has made it possible to non-invasively deliver constructs to
the brain via systemic injection [54, 55]. Systemic gene de-
livery eliminates confounds that might arise from direct in-
jections into the brain and was recently used successfully
for real-time monitoring of large-scale cortical activity rele-
vant for proper olfaction [56] and vision [57]. Coupled with
opsin variants that are activated by far-red light [58], which
can more readily penetrate tissue, it is possible in principle
to manipulate neuronal activity without major surgery and
the associated confounding factors.
Can optogenetic techniques be used to study the
peripheral nervous system?
Unlike in the brain, where neurons are densely clustered
in well-defined nuclei, neurons in the peripheral nervous
system (PNS) are contained in separated ganglia con-
nected by a complex, far-reaching network. Separately, the
spinal cord, a critical modulator of sensory and motor
function, is delicate, hard to access through bone, and eas-
ily affected by movement. These factors complicate both
opsin delivery via local injection and photoactivation via
optical fiber placement in these regions. New approaches
are being developed to improve opsin delivery to the
spinal cord and PNS, including the use of novel viral cap-
sids with high affinity for peripheral neurons, which can
express opsins in the desired locations after systemic in-
jection [54, 55]. Light delivery strategies must also be opti-
mized for the spinal cord or peripheral tissue as they
cannot easily be targeted with fiber optics. This has led to
a broad range of tactics for peripheral illumination that in-
clude epidural fiber implants [59] and polymer-based
optic cuffs [60]. Such developments can bridge the current
gap between optogenetic CNS and PNS studies.
What are the preferred imaging devices for
optogenetics?
Besides the traditional fluorescence microscope, several im-
aging devices/systems are available for acquiring calcium in-
dicator signals, such as fiber-photometry, two photon
microscopy, implantable miniature microscopes, and
macroscopes [61]. Fiber photometry operates by recording
population activity through a relatively large (~ 400 μm
diameter) ceramic optical fiber that is implanted above an
area of interest in the brain. During the recording interval,subjects are freely behaving, and multiple color channels
can be simultaneously recorded using the same fiber. While
fiber photometry is an easy-to-use and relatively econom-
ical system, it lacks spatial resolution because the recorded
signal is an accumulation of the fluorescence intensity from
activity of the entire population. Two-photon microscopy
mitigates the spatial resolution drawback of fiber-
photometry and is capable of recording neuronal activity
with sub-cellular resolution and an excellent signal-to-noise
ratio. Two-photon microscopes can scan volumes of inter-
est using a piezo-controlled objective. To extend the work-
ing distance of the objective lens and to image deep brain
areas, two-photon microscopes can also image through im-
planted GRIN lenses. However, two-photon microscopy re-
quires substantial capital investment and animals must be
head fixed, thus restricting the scope of behavioral experi-
ments that can be conducted. To address this limitation,
light-weight (< 3 grams), miniature fluorescence micro-
scopes have been developed and can be directly implanted
on top of a mouse’s head [62, 63]. Following implantation,
the miniature microscope records real-time neuronal activ-
ity from freely moving animals at single-cell resolution.
Miniature microscopes are commercially available and can
also be assembled with the guidance of on-line tutorials
provided by the miniscope open-source community [64].
The technology behind miniature implantable microscopes
is rapidly developing, and a two-photon version was re-
cently introduced in freely behaving animals [65]. Finally,
when studying superficial brain areas using a cranial win-
dow, an extremely wide field of view of up to 20 mm in
diameter can be recorded using a macroscope, which can
reveal cortex-wide activity patterns with a small comprom-
ise in resolution [56, 66].What is the typical size of a dataset, and how do
you manage them?
Both TC and live imaging techniques generate a large
number of images in order to create a 3-D volume or
time-series dataset. Three-dimensional imaging of
cleared tissue usually creates tens to hundreds of
gigabytes (GB) of data for a single experiment, thus
requiring not only large computational power for 3-D
visualization, but also extensive storage capacity. Sac-
rificing resolution in order to reduce the acquired
dataset dimensions to a manageable size is a reason-
able trade-off, as long as the biological question can
be addressed within the lower-resolution dataset.
Similarly, time-series image datasets acquired from
calcium-imaging experiments can be post-processed
and converted to a compact format, which contains
only the average intensity per cell in time. To manage
and to access the acquired data easily, a workstation
with enough memory to handle big datasets
Greenbaum et al. BMC Biology  (2017) 15:87 Page 7 of 10(hundreds of GB) and with secured network-attached
storage (NAS) is a practical option.
Sharing large datasets with distant collaborators is an-
other challenge. Commercial cloud services provide a
convenient solution, even if the data transfer speed is
relatively slow and the storage space is generally limited.
Omero [67], a server system specifically designed for sci-
entific images, could be another option for this purpose.
What are the tools and challenges for data
analysis?
One difficulty in analyzing TC data arises from optical limi-
tations in 3-D imaging, such as chromatic aberrations in
multi-colored images, which requires post-processing of
the data. ImageJ (FIJI) [68], an open-source platform for
image processing, includes a suite of useful plugins such as
a 3-D viewer, versatile file-format converters, and image
filters. Commercial data visualization software, such as
Imaris or Amira, can render large 3-D volumes seamlessly,
although they only provide simple functions for processing
3-D images. None of the above software can stitch a large
volume that is composed of multiple tiles, and the
open-source tool TeraStitcher [69] is a good solution for
this purpose. For satisfying stitching results, at least 10%
overlap between tiles is required.
Cell morphology is of particular interest in neuroscience
owing to its association with function and neural diseases.
However, 3-D reconstruction and digitization of fine neur-
onal morphology remains challenging. One reason is that
cells in the nervous system are densely packed, making it
difficult to distinguish one from another. Despite many at-
tempts to solve this problem, automated tracing of neur-
onal morphology is highly limited to specific cell types
and labeling methods. For manual tracing, the Imaris
module, FilamentTracer, is useful. Among open-source
tools, neuTube [70] is another good option, though it only
supports grayscale images (Fig. 3).
Although there are various software tools that attempt to
tackle these numerous challenges, each of them typically fo-
cuses on one specific task—such as stitching, visualization,
or deconvolution—and receives a distinct file format as in-
put, requiring file-type conversions for further processing.
Consequently, sequential use of these tools is a tedious and
bewildering process. There is a need for a unified computa-
tional framework or a shared file standard so that these
software tools can interface in a seamless manner.
What are the examples beyond neuroscientific
applications?
Beyond the brain, TC techniques have been applied to
other organs [11] such as the skin [10], heart [71], pan-
creas [10, 72], and tongue [73] to reconstruct their 3-D
structure and identify anatomical changes under abnormal
conditions. For example, TC was used to study cancermetastasis at cellular resolution in whole-body cleared
mice [15, 74], as well as to characterize axon regeneration
and glial response after injury in the spinal cord [16].
In addition, bone, which has a unique composition of
both hard (mineral) and soft (bone marrow) tissue [75],
can also be rendered transparent with a tailored clearing
protocol, Bone CLARITY [17]. Bone CLARITY uses
EDTA to remove minerals that make the bone rigid and
8% SDS to remove lipids, the primary source of light scat-
tering in biological tissue. This technique is also able to
maintain the native fluorescence of reporter mouse lines.
When paired with light sheet microscopy, Bone CLARITY
can detect rare and non-uniformly distributed stem cells
within the bone marrow at single cell resolution in the
long bones and vertebral bodies of adult mice. Further-
more, this provides a way to assess therapeutic candidates
for osteoporosis.
The ability of hydrogel-based TC techniques to lock
molecules in place also enables us to investigate the
spatial distribution of pathogens in specimens. Our re-
cent study applied the PACT technique to capture spu-
tum collected from cystic fibrosis patients and showed
in situ characterization of bacterial physiology [30].
Spreading patterns of viruses, such as HIV-1, have also
been studied by applying TC techniques to lymphoid tis-
sue [76]. These examples suggest the potential applica-
tions of TC techniques to prokaryotic organisms and the
diagnosis of infectious diseases.
Although optogenetic tools have been most widely
used to further our understanding of neuronal function,
they have also been used to manipulate the activity of
other cell types such as astrocytes [77] and cardiomyo-
cytes [78]. Additionally, several effectors have been
engineered to manipulate other biological events,
including intracellular transport [79], signaling
pathways [80], gene expression [81], and protein as-
sembly [82].
What are the future directions of tissue clearing
and optogenetics?
Applicable from the soft brain to the hard bone, TC
methods allow us to study the structure and connectivity
of whole organs in unprecedented resolution and detail.
As mentioned above, the handling, management, and
analysis of TC datasets remains an unsolved challenge,
hindering biological discoveries. The quality, uniformity,
and cost of antibody labeling are additional challenges
for TC. Thus, addressing the need for a unified compu-
tational framework and low-cost small-molecule labeling
methods is paramount for the successful integration of
TC techniques into the life sciences and medicine.
The combination of discrete expression and high tem-
poral resolution has led to the use of optogenetics to study
the brain; however, there is much to be addressed in the
a b c
Fig. 3. Viral-assisted spectral tracing of mouse cerebellum. a Multi-color neurons, labeled with a two-component viral delivery system. Two viral
vectors carrying ssAAV-PHP.eB:TET-DIO-XFP (XFP =mNeonGreen, mTurquiose2, or mRuby) and ssAAV-PHP.eB:ihSyn-tTA-WPRE were injected into the
retro-orbital sinus of an adult mouse. After 3 weeks of expression the animals were sacrificed and the brain was cut into 300 μm thick sections. The
section was optically cleared in refractive index matching solution (RIMS) and then imaged using a confocal microscope. Refer to [55] for details.
b Using the 3-D volume data, five Purkinje cells were manually traced in NeuTube and their traces overlaid on the 3-D volume. c Traces of the five
Purkinje cells from b
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is invasive as it often requires the injection of viral vectors
for cell-specific expression, implantation of fiber optics to
target a specific region, and chronic optical stimulation.
Tools are rapidly being engineered to solve these issues. Re-
cently developed novel capsids allow viral particles to
traverse the blood–brain barrier and achieve high gene ex-
pression throughout the brain, thus beginning to overcome
the barriers that stand in the way of efficient, non-invasive
gene delivery [54, 55]. Opsins are also continuously being
engineered to address obstacles concerning light delivery.
Recent variations of the Channelrhodopsin protein include
a variant that is activated at far-red shifted wavelengths,
which enables activation at greater tissue depths, and a
bistable variant that only requires brief pulses of light to
switch between ‘on’ and ‘off ’ states [83]. Novel environ-
ments are also being developed to take advantage of new
opsins, such as those that allow complete, wireless photosti-
mulation [84].
Emerging from the field of neuroscience, TC and opto-
genetics now constitute a powerful approach to the
study of general biological questions and diseases by en-
abling the control and measurement of functional
changes in living tissue [85], followed by cellular and
molecular phenotyping at the whole-organ level.
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